Atreca (FRA:0C1) Marketable Securities : €7.42 Mil (As of Sep. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Atreca Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Atreca's Marketable Securities for the quarter that ended in Sep. 2023 was €7.42 Mil.

Atreca's annual Marketable Securities declined from Dec. 2020 (€147.38 Mil) to Dec. 2021 (€19.72 Mil) but then increased from Dec. 2021 (€19.72 Mil) to Dec. 2022 (€37.45 Mil).

Atreca Marketable Securities Historical Data

The historical data trend for Atreca's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Atreca Marketable Securities Chart

Atreca Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Marketable Securities

Get a 7-Day Free Trial

13.20

147.38

19.72

37.45

Atreca Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Marketable Securities	Get a 7-Day Free Trial															65.47	37.45	15.79	10.01	7.42

Atreca Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Atreca (FRA:0C1) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Atreca Marketable Securities Related Terms

Thank you for viewing the detailed overview of Atreca's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Atreca (FRA:0C1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Atreca Inc (FRA:0C1) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

BCEL:USA 0C1:Germany

Address

835 Industrial Road, Suite 400, San Carlos, CA, USA, 94070

Website

https://www.atreca.com

Atreca Inc is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types. It has single segment business of therapeutic drug discovery and development. The company's product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism of action and target derived from an antibody identified using its discovery platform.

Atreca (FRA:0C1) Headlines

No Headlines